BREAST CANCER DIAGNOSTIC AND DRUG TECHNOLOGIES: GLOBAL MARKETS

Breast Cancer Diagnostic and Drug Technologies: Global Markets

The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019.

This report provides:
-An overview of the global market for breast cancer diagnostics and drug technologies.
-Analyses of market trends, with data from 2012, estimates for 2014, and projections of CAGRs through 2019.
-A comprehensive review of emerging breast cancer personalized and predictive diagnostic tests, particularly with regard to companion tests, tumor markers, and gene profiling assays relevant for breast cancer prognosis and diagnosis.
-Information on products in the market and detailed analyses of the market's segments and competitive environments.
Assessments of technological developments, product innovations, and recent strategic industry activity of across different product categories.
-Comprehensive company profiles of major players in the industry.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
This market report has been updated to serve the strong interest shown in the previous version by the same author. This BCC market research report provides a detailed overview and thorough analysis of the present and future global market for breast cancer diagnostics and drug technologies. It provides detailed analysis of the market as well as the personalized, predictive and companion tests that are currently used and their markets. New key developments are underscored. The research also includes market characterization, opportunities, unmet needs associated with breast cancer, competitive assessment, product profiles of major marketed products and promising drugs in the pipeline, an overview of discontinued projects, implications for future market competition and the key players in the breast cancer drug and diagnostics market.

Read » Breast Cancer Diagnostic and Drug Technologies: Global Markets

Published 12 weeks 5 days ago – Made popular 12 weeks 4 days ago
Category: Health | Tags:

Login or register to post comments

Stories similar to Breast Cancer Diagnostic and Drug Technologies: Global Markets:

Additional information on Breast Cancer Diagnostic and Drug Technologies: Global Markets :
- Aug 4, 2014 ... Global Breast Cancer Market by Segments (2013E) Global Breast Cancer Predictive Diagnostic and Drug Technologies (2010-2014E) The US ...
- Jun 26, 2012 ... Breast Cancer Diagnostic and Drug Technologies: Global Markets. The global market for breast cancer diagnostics and drug technologies ...
- Sep 1, 2014 ... The market is analyzed by cancer type: prostate, breast and colorectal. .... An overview of the global market for cancer diagnostics based on circulating tumor cells .... TABLE 81 GLOBAL CANCER DRUG MARKET SALES AND ...
- The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is ...
- Jun 22, 2012 ... The global market for Predictive Breast Cancer diagnostic and drug Technologies was valued at $23.4 billion in 2010 and came down to $21.2 ...
- Global Breast Cancer Market Analysis, Size, Share, Growth, Trends and Forecast 2014 ... Breast cancer is the most frequently diagnosed cancer and the leading cause of ... breast cancer treatment industry is the fact that novel and innovative technologies ... The market for breast cancer drugs represents an area of potential ...
- A detailed overview and thorough analysis of the present and future global market for breast cancer diagnostics and drug technologies. Includes forecasts ...
- The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is ...

Related links about Breast Cancer Diagnostic and Drug Technologies: Global Markets :
1. Breast Cancer Diagnostic and Drug Technologies ... - BCC Research
2. Breast Cancer Diagnostic and Drug Technologies: Global Markets ...
3. Report on the global market for breast cancer diagnostics and drug ...
4. Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global ...
5. Breast Cancer Diagnostic and Drug Technologies: Global Markets

Breast Cancer Diagnostic and Drug Technologies: Global Markets 24 weeks 6 days ago

REPORT HIGHLIGHTS

The global market for Predictive Breast Cancer diagnostic and drug Technologies was valued at $23.4 billion in 2010 and came down to $21.2 billion in 2011. This market is expected to rise at a compound annual growth rate (CAGR) of 2.5% and reach $24 billion by 2016.
The market for Breast cancer drugs reached $12.7 billion in 2010 and came down to $10.2 billion in 2011. The market is expected to reach $11.2 billion by 2016, a CAGR of 1.9%.

Therapeutics for Silent Cancers 1 week 1 hour ago

The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.

This report provides:
-An overview of the global markets and technologies for the therapeutics for "silent" cancers.
-Analyses of global market trends, with data from 2013, 2014, and projections of CAGRs through 2019.
-Descriptions of cancers, with incidence and prevalence data for all major national markets.
-Assessments of currently available therapies.

Cancer Profiling and Pathways: Technologies and Global Markets 24 weeks 2 hours ago

The global market for cancer profiling technologies reached $26.1 billion in 2012. This market is expected to grow to nearly $30.1 billion in 2013 and $54.8 billion in 2018, a compound annual growth rate (CAGR) of 12.8% over the five-year period, 2013 to 2018.

This report provides:

-An overview of the global market for cancer profiling and biomarker studies
-Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018

Cancer Profiling and Pathways Global Markets 1 year 2 weeks ago

The global market for cancer profiling technologies reached $26.1 billion in 2012. This market is expected to grow to nearly $30.1 billion in 2013 and $54.8 billion in 2018, a compound annual growth rate (CAGR) of 12.8% over the five-year period, 2013 to 2018.

This report provides:

-An overview of the global market for cancer profiling and biomarker studies
-Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018

Radiopharmaceuticals: Technologies and Global Markets 24 weeks 3 days ago

The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.

This report provides:
-An overview of the global market for radiopharmaceuticals and related technologies.
-Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.